A survey of known immune epitopes in the enteroviruses strains associated with acute flaccid myelitis.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 12 06 2019
revised: 08 08 2019
accepted: 16 08 2019
pubmed: 28 8 2019
medline: 4 4 2020
entrez: 28 8 2019
Statut: ppublish

Résumé

Enteroviruses are potentially linked to the emergence of Acute Flaccid Myelitis (AFM), a rare but very serious condition that affects the nervous system. AFM has been associated with coxsackievirus A16, enterovirus A71 (EVA71) and enterovirus D68 (EVD68). Little is known about host-pathogen interactions for these viruses, and whether immune responses may have a protective or immunopathological role in disease presentations. Towards addressing this issue, we used the Immune Epitope Database to assess the known inventory of B and T cell epitopes from enteroviruses, focusing on data related to human hosts. The extent of conservation in areas that are targets of B and T cell immune responses were examined. This analysis sheds light on regions of the enterovirus polypeptide that can be probed to induce a specific or cross-reactive B or T cell the immune response to enteroviruses, with a particular focus on coxsackievirus A16, EVA71 and EVD68. In addition, these analyses reveal the current gap-of-knowledge in the T and B cell immune responses that future studies should aim to address.

Identifiants

pubmed: 31451291
pii: S0198-8859(19)30608-1
doi: 10.1016/j.humimm.2019.08.004
pmc: PMC6876747
mid: NIHMS1538203
pii:
doi:

Substances chimiques

Antigens, Viral 0
Immunodominant Epitopes 0
Receptors, Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

923-929

Subventions

Organisme : NIAID NIH HHS
ID : 75N93019C00001
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Références

J Clin Virol. 2018 Aug;105:41-48
pubmed: 29886372
Immun Inflamm Dis. 2018 Mar;6(1):143-153
pubmed: 29124902
Nucleic Acids Res. 2012 Jan;40(Database issue):D593-8
pubmed: 22006842
F1000Res. 2018 Sep 24;7:
pubmed: 30345002
J Virol. 1995 Nov;69(11):6720-8
pubmed: 7474082
PLoS Curr. 2016 Nov 15;8:null
pubmed: 28018746
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Bioinformatics. 2018 Nov 15;34(22):3931-3933
pubmed: 29878047
Immunology. 2014 May;142(1):89-100
pubmed: 24329688
Mayo Clin Proc. 2019 May;94(5):875-881
pubmed: 31054607
Euro Surveill. 2018 Jan;23(3):
pubmed: 29386095
J Immunol Res. 2015;2015:763461
pubmed: 26568965
MBio. 2019 Apr 2;10(2):
pubmed: 30940708
J Immunol. 2013 Aug 15;191(4):1637-47
pubmed: 23863902
MMWR Morb Mortal Wkly Rep. 2019 Jul 12;68(27):608-614
pubmed: 31295232
J Virol. 2016 Nov 14;90(23):10459-10471
pubmed: 27630239
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
Curr Opin Pediatr. 2016 Feb;28(1):107-13
pubmed: 26709690
Virus Evol. 2016 Jun 15;2(1):vew015
pubmed: 28512577
Circ Res. 1999 Sep 17;85(6):551-8
pubmed: 10488058
Viruses. 2016 Jan 11;8(1):null
pubmed: 26761027
J Virol. 1999 Mar;73(3):1941-8
pubmed: 9971773
PLoS One. 2016 Nov 2;11(11):e0165659
pubmed: 27806091
J Clin Microbiol. 2009 Jun;47(6):1939-41
pubmed: 19386844
Nat Commun. 2017 Oct 2;8(1):762
pubmed: 28970483
J Clin Microbiol. 2006 Aug;44(8):2698-704
pubmed: 16891480
Curr Infect Dis Rep. 2018 Jun 29;20(9):34
pubmed: 29959591
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
MBio. 2018 Oct 16;9(5):
pubmed: 30327438
Front Microbiol. 2018 Feb 21;9:286
pubmed: 29515559

Auteurs

Alba Grifoni (A)

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA. Electronic address: agrifoni@lji.org.

Swapnil Mahajan (S)

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

John Sidney (J)

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

Sheridan Martini (S)

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

Richard H Scheuermann (RH)

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; J. Craig Venter Institute, La Jolla, CA 92037, USA; Department of Pathology, University of California, San Diego, CA 92093, USA.

Bjoern Peters (B)

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Department of Medicine, University of California, San Diego, CA 92093, USA.

Alessandro Sette (A)

Division of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Department of Medicine, University of California, San Diego, CA 92093, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH